-
Latest Advances in Non–Clear Cell RCC Treatment - 18 day(s) ago
Dear readers, The treatment paradigm for non-clear cell renal cell carcinoma (nccRCC) has evolved significantly, though it remains less clearly defined than that for clear…
Drs. Benjamin Garmezy & Manojkumar Bupathi
UrologyDrs. Manojkumar Bupathi and Benjamin Garmezy are expert healthcare providers in oncology and genitourinary cancers. Dr. Garmezy, of Sarah Cannon Research Institute, serves as the Associate Director of Genitourinary Research for the national network as well as the Co-Chair of the Executive Research Committee where he oversees investigational therapy trials for GU cancers, including prostate, kidney, testicular, and bladder cancers. Dr. Bupathi is a board-certified medical oncologist specializing in genitourinary cancers including adrenal, bladder, kidney, penile, prostate, and testicular. He was recently elected practice president for Rocky Mountain Cancer Centers and serves as the Co-Chair for US Oncology Genitourinary Cancer Research Program.
-
Treatment of Oligometastatic Prostate Cancer - 2 month(s) ago
Dear readers, What is the definition of oligometastatic prostate cancer? How do we best treat patients in this disease state? The true answer is that…